The use of the indirect immunofluorescence assay (IFA) for the detection and measurement of antibody to human cytomegalovirus (CMV) has been shown to be a useful tool in clinical laboratories. The most commonly employed method is the observation of fluorescent intranuclear inclusions in human CMV-infected cell cultures after incubation with the serum of the patient and the appropriate fluorescein-tagged antiserum. Due to the induction of Fc receptors in human fibroblasts by human CMV, a possible source of error was often encountered (4, 8, 10, 16) . Previous studies in this laboratory showed that the CSG strain of simian CMV did not induce such Fc receptors in human fibroblasts; therefore, cell cultures infected with the simian CMV strain could be substituted for the human CMV strain-infected cells in the IFA test (12) .
Enzyme-linked immunospecific assays (ETAs) have also been described for the detection of antibody to human CMV (2, 11, 14) . The increased sensitivity of enzyme-linked assays prompted the present investigation of the possible use of the CSG strain of simian CMV as an antigen. The EIA methodology was modified from that of Voller et al. (13) . All antigens used were passively adsorbed onto polystyrene microtiter plates. Antibody was detected by horseradish peroxidase-tagged rabbit anti-human immunoglobulin G (Cappel Laboratories, Downingtown, Pa.). Substrate was prepared from 2,2'-azino-di(3-ethyl-benzothiazoline-6'-sulfonate) ( Antibody titers for both human and simian sera were determined by the method previously described with IFA-CSG, i.e., cells infected with the CSG strain of CMV as the antigen (12) . Fluorescein-conjugated anti-human immunoglobulin G was prepared from the same lot of antiserum that was used for the horseradish peroxidase conjugate in EIAs. Both conjugates were used to assay both human and simian CMV antibodies. Simian serum samples were obtained from naturally infected African green and rhesus monkeys and from rhesus monkeys experimentally infected with the CSG strain of CMV. All simian species were housed at the Laboratory for Experimental Medicine and Surgery for Primates, New York University, Sterling Forest. During annual testing all simian species were found to be consistently negative for neutralizing antibody to human CMV. Table 1 demonstrates the reactivity of human and simian sera by EIA with AD 169 as the antigen (EIA-AD 169) or with CSG as the antigen (EIA-CSG) as compared with the IFA-CSG test. All human sera showing IFA-CSG titers of 1:4 or greater were also positive by EIA-AD 169. However, substitution of the human virus antigen with the simian virus antigen in the EIA technique produced unexpected results in that most human sera were negative by this technique. Those human sera which did react with the simian antigen did so at significantly lower levels of reactivity than shown with AD 169.
Antibody-positive sera obtained from monkeys naturally or experimentally infected with simian CMV were used to ensure that the simian virus antigen was adsorbed to the microtiter plates and was reactive. These sera were tested for antibody to CMV by IFA-CSG and compared with the EIA technique with both human and simian antigens. Of the 22 simian sera found positive by IFA-CSG, 19 were positive by EIA-CSG and 16 were positive by EIA-AD 169. No differences in reactivity were observed in sera obtained from naturally or experimentally infected monkeys.
In previous studies a one-way cross-reactivity between simian and human CMVs was demonstrated by complement fixation with cell-free virus stocks (1, 3) . Similarly, antisera produced in guinea pigs to highly purified human and simian CMVs also demonstrated this one-way cross-reactivity (7) . The results in the present study were consistent with previous findings but would appear to be in contrast to our previous report (12) .
To gain insight into the differences in reactivity between the human and simian CMV antigens, CSG antigen prepared by various methods was tested for reactivity with human or simian CMV-positive sera. Virus-infected cell culture preparations were subjected to differential centrifugation after freeze-thawing to remove cellular material. Cell-free virus concentrated 100-fold after ultracentrifugation was suspended in 10 ml of buffer. Microtiter plates were then coated with serial 10-fold dilutions of the 10Ox concentrated preparation. Sera which previously had been shown to be reactive by EIA-AD 169 but not by EIA-CSG were tested against this concentrated CSG antigen preparation. No reactivity was detectable at any of the dilutions of concentrated simian CMV antigen with the hu- man sera previously shown to be positive for antibody to the AD 169 strain of CMV. Additional manipulations of the simian antigen were performed in an attempt to expose antigens that might have been sequestered. These included additional cycles of freeze-thawing, a period of sonication as described by Huang (6) , and the use of alkaline glycine buffer extraction (9) . In each case no reactivity of the human sera with the simian antigen was found by EIA.
Because in the IFA-CSG procedure virusinfected cells were air dried and then treated with cold acetone, it was thought that such a procedure might have altered the nuclear membrane, exposing cross-reactive antigens which could then react with human CMV antibody. Our EIA was modified for performance in glass tubes, so that various concentrations of antigen could be treated with acetone while on the surface of the tube. The same pattern of results was obtained; i.e., human sera were reactive only with the AD 169 strain of human CMV antigens but not with the CSG strain of simian CMV antigens, whereas simian sera from both naturally and experimentally infected animals were reactive with both antigen preparations.
In the final procedure CMV-infected cells were simply scraped off the flask after the appearance of the characteristic cytopathic effect and concentrated by ultracentrifugation. Various dilutions of this preparation ("whole CSG") were made in microtiter plates and tested by EIA for reactivity with human and simian sera previously shown to have IFA titers of -1:4.
Human sera previously shown to be reactive in IFA-CSG but nonreactive to EIA-CSG were found to be reactive with the whole CSG antigen preparation (Table 2) . Sera nonreactive to EIA-AD 169 remained nonreactive to the whole CSG.
All sera were nonreactive when tested with control antigens of concentrated noninfected cells.
From these results it appeared that the crossreactive antigens were associated with cellular components of CSG antigens since only those preparations containing all the products of viral and cellular syntheses showed measurable reaction of CMV antibody-positive human sera to the simian virus. It seems plausible that the present data, which contrasted with those observed by IFA, were a result of the crossreactive antigen being removed during the preparation of partially purified cell-free virus. Perhaps what appears to be a cell-associated cross-reactive simian antigen is similar to the early antigen described for human CMV (5, 15) .
Alternately, it may be an antigen coded for by both human and simian CMVs but not incorporated into mature simian CMV particles. Finally, although the simian antigen may be substituted in the IFA technique, successful application of the latter antigen in an EIA requires the use of concentrated but unpurified antigen preparations.
